Skip to main content
Aurobindo Pharma Limited (NSE:AUROPHARMA)
India flag India · Delayed Price · Currency is INR
1,217.60
-5.50 (-0.45%)
At close: Dec 5, 2025

Aurobindo Pharma Revenue

Aurobindo Pharma had revenue of 82.86B INR in the quarter ending September 30, 2025, with 6.28% growth. This brings the company's revenue in the last twelve months to 325.14B, up 7.33% year-over-year. In the fiscal year ending March 31, 2025, Aurobindo Pharma had annual revenue of 317.24B with 9.39% growth.

Revenue (ttm)
325.14B
Revenue Growth
+7.33%
P/S Ratio
2.17
Revenue / Employee
11.74M
Employees
27,707
Market Cap
707.18B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025317.24B27.22B9.39%
Mar 31, 2024290.02B41.46B16.68%
Mar 31, 2023248.55B14.00B5.97%
Mar 31, 2022234.55B-13.19B-5.32%
Mar 31, 2021247.75B16.76B7.26%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sun Pharmaceutical Industries 549.64B
Divi's Laboratories 100.29B
Cipla 279.66B
Apollo Hospitals Enterprise 232.65B
Zydus Lifesciences 244.94B
Mankind Pharma 135.46B
Alkem Laboratories 138.90B
Fortis Healthcare 84.37B
Revenue Rankings

Aurobindo Pharma News

More News